Connecting clinical care, data and research
PartnershipsContact
← Back to publications

RESEARCH PUBLICATION / 2025

Correspondence / Letter

Survival benefit of tofacitinib in interstitial lung disease associated with anti-MDA5-positive dermatomyositis: a need for further validation.

The European respiratory journal

Citation & Authors

Eur Respir J. 2025;66(1):2500306.

Chih-Wei Tseng; James Cheng-Chung Wei

Abstract & Original paper

No abstract is available in the public index. Please consult the original paper.

Go to journal page